Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma
Open Access
- 30 April 2020
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2020, 1-12
- https://doi.org/10.1155/2020/1631843
Abstract
AGO2 (Argonaute RISC Catalytic Component 2) plays an important role in small RNA-guided gene silencing processes. It has been implied in tumorigenesis of different types of tumors. In this study, we found that AGO2 expression was remarkably increased in human hepatocellular carcinoma (HCC) tissues when compared with adjacent noncancerous tissues. High expression of AGO2 was associated with poor prognosis in HCC patients. The CRISPR/Cas9-mediated knockout of AGO2 in SMMC-7721 cells inhibited cell proliferation and induced significant G1 phase arrest of cell cycle. Inhibition of cell migration was also observed in SMMC-7721 AGO2(-/-) cells. In vivo experiments showed that tumors grew slower in nude mice transplanted with AGO2(-/-) cells than in SMMC-7721 cell-derived xenograft mice. Microarray analysis and western blot analysis revealed that AGO2 depletion decreased expression of Survivin, Vimentin, and Snail. Overexpression of AGO2 in SMMC-7721 and Huh-7 cells could reverse the knockout-induced inhibition effects on either cell behaviors or expression of Survivin, Vimentin, and Snail Therefore, our data demonstrated that AGO2 might facilitate HCC tumorigenesis and metastasis through modulating expression of Survivin, Vimentin, and Snail.Funding Information
- Hubei Provincial Health and Family Planning Scientific Research Project of China (WJ2019M128, 2019CFB449)
This publication has 27 references indexed in Scilit:
- Survivin in survival of hepatocellular carcinomaCancer Letters, 2016
- Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomasCellular Oncology, 2015
- Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinomaActa Pharmacologica Sinica, 2015
- CXCR2/CXCL5 axis contributes to epithelial–mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signalingCancer Letters, 2015
- Argonaute 2: A Novel Rising Star in Cancer ResearchJournal of Cancer, 2015
- An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinomaMolecular Medicine Reports, 2014
- Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinomaHepatology, 2012
- Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell CarcinomaClinical Cancer Research, 2008
- Argonaute2 Is the Catalytic Engine of Mammalian RNAiScience, 2004